SATVI authors Professor Mark Hatherill, Associate Professor Tom Scriba and Dr Munyaradzi Musvosvi have co-authored a paper titled "The SIGLEC14 null allele is associated with Mycobacterium tuberculosis- and BCG-induced clinical and immunologic outcomes" appearing in the Tuberculosis Journal.
Researchers from the South African Tuberculosis Vaccine Initiative, the universities of Stanford, Oxford and the London School of Hygiene & Tropical Medicine, have shown that a blood test usually used to detect tuberculosis infection in adults, can predict the onset of tuberculosis disease in young children. This article features in the latest Lancet: Respiratory Medicine.
UCT Health Sciences Faculty recently said farewell to Professor Greg Hussey, founding Director of SATVI, (Director: Vaccines for Africa and Interim Director of the HSF 2015-2016) upon his retirement.
SATVI author, Associate Professor Tom Scriba has co-authored a paper titled "Safety and Immunogenicity of Adenovirus 35 TB Vaccine Candidate in Adults with Active or Previous TB: a Randomized Trial" appearing in the American Journal of Respiratory and Critical Care Medicine.